Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Overview of attention for article published in The Lancet, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 34 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 610 X users
patent: 5 patents

facebook: 1 Facebook page
reddit: 4 Redditors
video: 1 YouTube creator
podcasts: 2 podcasts

Readers on

mendeley: 262 Mendeley

So far, Altmetric has seen 38 news stories from 34 outlets.

Effect of 2 priming doses of different anti-COVID19 vaccines - journalbreak

journalbreak.Com, 29 Dec 2022

Introduction According to the latest available data (late July 2022), the severe acute respiratory syndrome coronavirus (SARS-CoV…

AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19

Zawya, 26 May 2022

AstraZeneca's COVID-19 vaccine has been granted approval in the European Union (EU) by the European Medicine Agency (EMA) as a…

AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19

Business Ghana, 24 May 2022

AstraZeneca's (AstraZeneca.com) COVID-19 vaccine has been granted approval in the European Union (EU) by the European Medicine…

AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19

MarketScreener, 24 May 2022

(www.AstraZeneca.com) COVID-19 vaccine has been granted approval in the (EU) by the (EMA) as a third dose booster in adults.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 34 additional news stories.